AzTrials
AzTrials

Pilonidal SinusNCT03424057

Asymmetric Primary Closure and Additional Skin Excision Technique.

A study testing Asymmetric Primary Closure and Additional Skin Excision Technique and Standard Karydakis technique. in people with Pilonidal Sinus and Pilonidal Disease of Natal Cleft, run by Siverek Devlet Hastanesi.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of this study was to reduce the residual dead-space volume with a modification following the standard Karydakis procedure. Read more about this study

Who is it for?
Ages 18 to 65 yearsHealthy volunteers can take part
What is being tested?
Asymmetric Primary Closure and Additional Skin Excision Technique and Standard Karydakis technique.
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
100 participants
Where
No sites listed yet
Study dates
15 Apr 2015to 15 Apr 2016
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • All patients between age of 18-65 who had chronic pilonidal disease

Who cannot join

  • Patients who did not accept the procedure
  • Patients had undergone previous pilonidal sinus surgery
  • Patientshad active infection
  • Patients who were not minimum of 18 years of age

About this study

Official title: A Novel Technique in the Treatment of Sacrococcygeal Pilonidal Sinus Disease: Effect of Reduction of Dead-space With Asymmetric Primary Closure and Additional Skin Excision Technique.

The aim of this study was to reduce the residual dead-space volume with a modification following the standard Karydakis procedure.

Read the detailed description

All patients were operated in the jack-knife position under spinal anesthesia (SA). The gluteal parts of the patients were stretched in both directions with bandage and intergluteal cleft was opened. Methylen blue was administered from the sinus openings in the gluteal region. Then, total sinus excision was performed, including the entire sinus tracts by passing the skin, subcutaneous tissues up to the presacral fascia.

In patients operated with standard Karydakis procedure, a flap (Karydakis flap) extending along the incision was prepared, with the medial side of the wound to be 1 cm deep and 2-3 cm inward. The prepared flap was shifted to medial and sutured to the presacral fascia with 2/0 vicryl.

In patients who were operated with the Asymmetric Primary Closure with Skin Excision Technique, after the Karydakis flap was formed, 5-10 mm skin was excised along the incision from the side of the flap to reduce the volume of the dead-space laterally.

In both groups, subcutaneous tissue was approximated with 2/0 vicryl. The skin was sutured with mattress technique using 2/0 Prolene. No drains were used in patients from either group.

Patients were followed up for wound leakage, seroma and hematoma formation, skin dehiscence and recurrence.

Being tested
Asymmetric Primary Closure and Additional Skin Excision Technique, Standard Karydakis technique.
Keywords
Karydakis modification, pilonidal sinus, seroma
Medical subject headings
Pilonidal Sinus, Seroma

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Asymmetric Primary Closure and Additional Skin Excision TechniqueProcedure or surgery

    In this new technique, following total sinus excision, the excision defect was closed with the standard Karydakis method, but an advancement tissue flap was performed using additional skin excision, in order to reduce the dead-space volume.

  • Standard Karydakis technique.Procedure or surgery

    In this new technique, following total sinus excision, the excision defect was closed with the standard Karydakis method

Study groups in NCT03424057
Study groupRoleWhat they receive
Group 1ExperimentalGroup 1 were treated with the new technique (Asymmetric Primary Closure and Additional Skin Excision). In this new technique, following total sinus excision, the excision defect was closed with the standard Karydakis method, but an advancement tissue flap was performed using additional skin excision, in order to reduce the dead-space volume.
Receives: Procedure: Asymmetric Primary Closure and Additional Skin Excision Technique
Group 2Active comparatorGroup 2 were treated with the standard Karydakis technique.
Receives: Procedure: Standard Karydakis technique.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Early postoperative complications.

    wound dehiscence, formation of seroma, hematoma, wound infection

    Measured: 3 years

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Feb 2018
  2. Study start15 Apr 2015
  3. Primary completion25 Mar 2016
  4. Study completion15 Apr 2016

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
100 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03424057
Sponsor's protocol ID
74059997.050.01.04/79
Status last verified
Feb 2018
First submitted
30 Jan 2018
Last updated
6 Feb 2018
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: The study has been completed. The datas will be shared as an article

Questions about this trial

What is this clinical trial studying?

A study testing Asymmetric Primary Closure and Additional Skin Excision Technique and Standard Karydakis technique. in people with Pilonidal Sinus and Pilonidal Disease of Natal Cleft, run by Siverek Devlet Hastanesi.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 6 Feb 2018. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Early postoperative complications. (time frame: 3 years). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Feb 2018.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in